The Effectiveness of Using Misopostol and Oxytocin in Handling Post Partum Hemorrhage at the Rangga Medika Cikampek Clinic, Karawang Regency in 2022
DOI:
https://doi.org/10.33755/jkk.v9iSpecial%20Edition.564Keywords:
misoprostol and oxytocin, postpartum hemorrhageAbstract
Aims : This study aims to determine the effectiveness of the use of misoprostol and oxytocin in the treatment of postpartum hemorrhage at Rangga Medika Clinic, Karawang Regency in 2022.
Methods : is an analytical method with a cross sectional approach. The research was conducted at Rangga Medika Clinic, Karawang Regency. Research data using observation sheets. The number of respondents as many as 30 people. Data analysis used dependent t-test.
Results : The results showed that the results of the dependent t test (paired t test) showed that there was a difference in the use of misoprostol and oxytocin in the treatment of postpartum hemorrhage with p<0.05.
Conclusions : The young age of the reproductive organs and inadequate physiological functions affect pregnancy acceptance and the postpartum period. The majority of respondents were of a healthy reproductive age between 20 and 35 years, with high-risk pregnancies occurring after that age.
References
Unicef. Managing complications in pregnancy and childbirth: a guide for midwives and doctors. 492. 2017;
Anugerah I, Iswari WA, Pardede TU, Darus F, Puspitasari B, Santana S, et al. Tatalaksana retensio urin pasca persalinan. Cermin Dunia Kedokteran. 2017;44(8):531–6.
Kramer MS, Dahhou M, Vallerand D, Liston R, Joseph KS. Risk factors for postpartum hemorrhage: can we explain the recent temporal increase? Journal of Obstetrics and Gynaecology Canada. 2011;33(8):810–9.
Cameron EE, Sedov ID, Tomfohr-Madsen LM. Prevalence of paternal depression in pregnancy and the postpartum: an updated meta-analysis. J Affect Disord. 2016;206:189–203.
Hapsari SK. Pencegahan Kematian Ibu dan Anak melalui Pendekatan Strategi Komunikasi pada Program EMAS (Expanding Maternal and Neonatal Survival). Jurnal Ilmu Komunikasi. 2016;14(3):165–74.
Das R, Biswas S. Eclapmsia: The major cause of maternal mortality in Eastern India. Ethiop J Health Sci. 2015;25(2):111–6.
Sugiyono PD. Quantitative, qualitative, and R&D research methods. Bandung:(ALFABETA, Ed). 2018;
Regen S, Yanuarti T. Efektifitas Penggunaan Misoprostol Dan Oksitosin Pada Penanganan Perdarahan Post Partum Di BPM Suryati Bekasi. Malahayati Nursing Journal. 2022;4(4):840–52.
Koch DM, Rattmann YD. Use of misoprostol in the treatment of postpartum hemorrhage: a pharmacoepidemiological approach. Einstein (Sao Paulo). 2019;18.
Atukunda EC, Siedner MJ, Obua C, Mugyenyi GR, Twagirumukiza M, Agaba AG. Sublingual misoprostol versus intramuscular oxytocin for prevention of postpartum hemorrhage in Uganda: a double-blind randomized non-inferiority trial. PLoS Med. 2014;11(11):e1001752.
Chaudhuri P, Biswas J, Mandal A. Sublingual misoprostol versus intramuscular oxytocin for prevention of postpartum hemorrhage in low-risk women. International Journal of Gynecology & Obstetrics. 2012;116(2):138–42.
